BioSpace News Archive

Samsung Bioepis’ BRENZYS™ becomes available in Brazil through Brazil’s public health system, Sistema Único de Saúde

Bluestar Genomics, a company developing innovative, data-driven, epigenomic approaches to comprehensive disease analysis and diagnostics, has announced the presentation of data demonstrating the feasibility of a blood test, based on genome-wide profiling of 5-hydroxymethylcytosine (5hmC) in cell-free DNA, providing earlier detection and classification of multiple cancers

Geo-Med & Xenex Enhance Veteran Safety with Infection Prevention Programs Utilizing LightStrike Germ-Zapping Robots

Introduction in the US of Cyspera, a breakthrough topical solution for stubborn skin discoloration, through a new partnership between Scientis, the Swiss original brand manufacturer, and SENTÉ, a specialty aesthetics company

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that J.J. Finkelstein, President and Chief Executive Officer, will present a corporate update at the Fall Investor Summit on September 17, 2019, at 8:30 a.m. ET in New York City.

Rapha Pharma today announced that it has registered Dermatropin Transdermal HGH gel with the US Food and Drug Administration (FDA) and has received a New Drug Code to market the homeopathic drug directly to consumers, without a prescription, through its official website http://www.buydermatropin.com

Nanion is pleased to announce the launch of the FLEXcyte 96 technology for cardiac contraction force measurements. Improving patient safety and reducing animal tests while saving time and money by replacing unnecessary in vivo experiments is the aim of this novel assay technology.

Reed Technology and Information Services Inc. (Reed Tech), a leading provider of data management and analytics solutions for the life sciences industry, and 1WorldSync™, the leading provider of product content solutions, have expanded their collaboration to include a full-service solution for medical device manufacturers to manage regulatory and commercial product information, including UDI (Unique Device Identifier) submissions to EUDAMED (European Union Databank on Medical Devices).

The Company’s GPR174 Inhibitors Enhance Anti-Tumor Activities of Adenosine Pathway Inhibitors by up to 25-Fold

New white paper challenges industry to look beyond behavioral access issues; explores the effect of MBC on value-based care